Burney Company’s CorMedix CRMD Stock Holding History

Burney Company’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$67.9K	–	619
2026 Q1	$67.9K	Hold	10,000	–	–	﹤0.01%	578
2025 Q4	$116K	Hold	10,000	–	–	﹤0.01%	603
2025 Q3	$116K	Hold	10,000	–	–	﹤0.01%	579
2025 Q2	$123K	Hold	10,000	–	–	﹤0.01%	570
2025 Q1	$61.6K	Hold	10,000	–	–	﹤0.01%	569
2024 Q4	$81K	Hold	10,000	–	–	﹤0.01%	580
2024 Q3	$80.8K	Hold	10,000	–	–	﹤0.01%	596
2024 Q2	$43.3K	Hold	10,000	–	–	﹤0.01%	592
2024 Q1	$42.4K	Hold	10,000	–	–	﹤0.01%	595
2023 Q4	$37.6K	Hold	10,000	–	–	﹤0.01%	578
2023 Q3	$37K	Hold	10,000	–	–	﹤0.01%	562
2023 Q2	$39.6K	Buy	+10,000	New	+$49.5K	﹤0.01%	571

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Burney Company's CRMD Position: Q2 2026 in Review

Burney Company sold out of CorMedix (CRMD) in Q2 2026, closing a stake of 10,000 shares — an estimated $67.9K sold.

Burney Company first reported a position in CRMD in Q2 2023 and held it in 12 quarters. The position peaked at $123K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Burney Company reported no remaining CorMedix position as of Q2 2026 after selling out during the quarter.
Burney Company sold 10,000 CorMedix shares in Q2 2026, an estimated $67.9K.
Burney Company first reported a position in CorMedix in Q2 2023 and held it in 12 quarters.
Burney Company's CorMedix position peaked at $123K in Q2 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.